account_circle info brightness_medium left_panel_close view_agenda grid_view

expand_moreexpand_less

Bosnia & Herzegovina

World

favorites

archive

We use cookies to provide some features and experiences in QOSHE

More information . Close

Graduate job cull spells doom for college degrees

Aimee Donnellan

Unilever ice cream spinoff needs a scoop of hope

Aimee Donnellan

Big Coffee’s next brew may be smaller and weaker

17.11.2025 10

Aimee Donnellan

Big Pharma Trump toadying stores up bigger battles

Aimee Donnellan

Pfizer’s obesity win is new formula for pharma M&A

Aimee Donnellan

AI sets up Kodak moment for global consultants

24.10.2025 10

Aimee Donnellan

Nestlé cuts are appetiser for bigger shake-up

Aimee Donnellan

AstraZeneca’s New York shift augurs London exodus

Aimee Donnellan

Obesity kings’ buffet is slimmer than it looks

02.10.2025 10

Aimee Donnellan

AstraZeneca’s game of exit chess puts UK in check

Aimee Donnellan

Big Pharma’s tariff win leaves lingering aches

Aimee Donnellan

Trump investment gifts only partly offset UK gloom

Aimee Donnellan

Budweiser brews some sobering mega-deal lessons

16.09.2025 20

Aimee Donnellan

AstraZeneca picks canny time to shake down the UK

Aimee Donnellan

Latest Nestlé CEO exit is chance for bigger reset

Aimee Donnellan

GSK revenue hole raises chances of risky M&A move

Aimee Donnellan

Big Pharma pioneers the TOFU tariff trade

Aimee Donnellan

Big Cannabis puts its growth hopes in dud buds

14.07.2025 20

Aimee Donnellan

Donald Trump’s tariff scattergun will miss target

09.07.2025 10

Aimee Donnellan

Shein disclosure row flags London’s IPO quandary

Aimee Donnellan

AI arms race is only just getting started: podcast

06.06.2025 60

Aimee Donnellan

Wild market swings are good reason to take stock: podcast

30.05.2025 10

Aimee Donnellan

Shein’s IPO setback is the least of its problems

Aimee Donnellan

Gold glistens brighter in a chaotic world: podcast

Aimee Donnellan

Big earnings reactions dent public market’s appeal

Aimee Donnellan

Nestlé bets biggest in brand giants’ tariff casino

Aimee Donnellan

Pauses, tweaks and can-kicking are new trade norms: podcast

Aimee Donnellan

CK Hutchison deal is test of Chinese hospitality: podcast

Aimee Donnellan

CK Hutchison deal is test of Chinese hospitality: podcast

Aimee Donnellan

Obesity drug boom has a new pecking order

26.04.2025 10

Aimee Donnellan

The China-US trade war is set to keep spiraling: podcast

Aimee Donnellan

Barclays’ Brookfield schmuck insurance may flop

Aimee Donnellan

How Trump’s tariff turmoil scarred global markets: podcast

18.04.2025 20

Aimee Donnellan

US tariff mania keeps everyone on edge: podcast

Aimee Donnellan

Big Pharma has partial immunity from Trump tariffs

10.04.2025 10

Aimee Donnellan

‘Pro-growth’ M&A policing is a misnomer: podcast

28.03.2025 10

Aimee Donnellan

Insurers will struggle to dodge climate-change tab

27.02.2025 20

Aimee Donnellan

New Unilever CEO has a chance to revisit mega-M&A

Aimee Donnellan

German elections chart course for a lonely Europe: podcast

21.02.2025 10

Aimee Donnellan

Shein’s IPO haste implies an ill-fitting outcome

Aimee Donnellan

Consumer giants' growth no longer involves food

Aimee Donnellan

Bond chaos induces headaches worldwide: podcast

Aimee Donnellan

Big Booze speeds towards low-growth tobacco status

Aimee Donnellan

Hot topics of 2024 will smoulder into new year: podcast

Aimee Donnellan

Obesity giants will begin $80 bln M&A face-off

Aimee Donnellan

French political stalemate threatens its economy: podcast

Aimee Donnellan

AstraZeneca lacks good medicine for Chinese limbo

Aimee Donnellan

Gautam Adani is promise and peril of Indian growth: podcast

Aimee Donnellan

European pharma’s growth prescription: pivot to US

Aimee Donnellan

Shein margin wobble takes bite out of IPO value

Aimee Donnellan